Cross-neutralization of RBD mutant strains of SARS-CoV-2 by convalescent patient derived antibodies.

Yan LouWenxiang ZhaoHaitao WeiMin ChuRuihua ChaoHangping YaoJunwei SuYanan LiXiulan LiYu CaoYanyan FengPing WangYongyang XiaYushuan ShangFengping LiPingju GeXinglin ZhangWenjing GaoGaojie SongBing DuTingbo LiangYunqing QiuMingyao Liu

Published in: Biotechnology journal (2021)

These results indicate that the neutralizing human antibodies from the patient-derived antibody libraries have the potential to fight SARS-CoV-2 and its mutants in this global pandemic.

Keyphrases

sars cov
respiratory syndrome coronavirus
endothelial cells
wild type
escherichia coli
induced pluripotent stem cells
dengue virus
coronavirus disease
risk assessment